Study of Stapokibart Injection in Patients With Allergic Rhinitis

Clinical trial NCT06525597 · RECRUITING

Trial details

NCT number: NCT06525597
Sponsor: Keymed Biosciences Co.Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2024-09-30
Primary completion: 2025-10-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.